시장보고서

상품코드

1571676

저온 플라즈마 시장 규모, 점유율, 동향 분석 보고서 : 압력별, 용도별, 지역별, 부문별 예측(2024-2030년)

Cold Plasma Market Size, Share & Trends Analysis Report By Pressure, By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

저온 플라즈마 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 저온 플라즈마 세계 시장 규모는 2024년부터 2030년까지 15.8%의 강력한 CAGR로 2030년까지 3억 5,810만 달러에 달할 것으로 예상됩니다.

의료 분야에서 저온 혈장 사용의 증가와 병원내 감염(HAI) 사례의 증가는 세계 시장의 주요 촉진요인입니다. 의료 산업에서 플라즈마 기술은 오래 전부터 사용되어 왔으며 다양한 치료법을 개선하는 데 도움이 되고 있습니다. 저온 플라즈마의 주요 특성 중 하나는 박테리아를 죽이고 감염을 예방하는 능력입니다. 따라서 효과적인 치유 솔루션으로 작용할 수 있습니다. 또한 치유 과정을 촉진하고 환자의 불편함을 방지합니다.

저온 플라즈마는 만성 상처와 화상을 치료하는 데 사용됩니다. 다제내성(MDR) 박테리아를 포함한 박테리아 세포는 저온 플라즈마에 노출되면 즉시 죽는다. 메디컬 익스프레스, 메드테크 유럽이 발표한 기사에 따르면 유럽에서는 매년 약 400만 명이 치유되지 않는 상처로 고통받고 있습니다. 또한 독일에서 화상 환자가 프로토타입 플라즈마 치료를 받았다는 보고도 있습니다. 또한 미국 국립생물공학정보센터(NCBI)가 발표한 연구에 따르면 2도 화상을 입은 환자를 저온 플라즈마로 치료한 결과 가려움증과 통증이 가라앉고 두 번째 치료 후 새로운 조직이 나타났다고 합니다. 이러한 사례는 다양한 상처 치료에 저온 플라즈마 사용을 촉진할 것으로 예상됩니다.

저온 플라즈마 시장 보고서 하이라이트

원자력 제품 부문은 2023년 65.5%의 가장 큰 매출 점유율을 차지하며 시장을 주도했습니다. 이러한 성장은 전자, 제조, 의료 등 다양한 응용 분야에서 대기압 저온 플라즈마 기술이 많이 사용되고 있기 때문입니다.
상처 치료 애플리케이션 부문은 2023년 31.0%의 가장 큰 매출 점유율을 차지하며 시장을 장악했습니다.
북미 저온 플라즈마 시장은 2023년 41.3%의 가장 큰 매출 점유율을 차지하며 세계 시장을 장악했습니다.

저온 플라즈마 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국
- 쿠웨이트

제8장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Bovie Medical Corporation.
- Neoplas med GmbH
- Europlasma NV
- P2i Ltd.
- US Medical Innovations;
- Apyx Medical.
- Adtec Healthcare Limited.
- terraplasma medical GmbH
- CINOGY System GmbH

ksm 24.11.01

Cold Plasma Market Growth & Trends:

The global cold plasma market size is expected to reach USD 358.1 million by 2030 at a strong CAGR of 15.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing use of cold plasma in medical treatment and rising cases of Hospital-Acquired Infections (HAI) are the key driving factors for the global market. In healthcare industry, plasma technology has been in use for some time and it continues to help improve various treatments. One of the major properties of cold plasma is the ability to kill bacteria and prevent infection. Therefore, it acts as an effective healing solution. It also accelerates healing process and prevent patient from discomfort.

Cold plasma is used in the treatment of chronic wounds and burns. The bacterial cells, including Multidrug Resistant (MDR) bacteria, are instantly killed after being exposed to cold plasma. As per an article published by the Medical Xpress, Med Tech Europe, around 4.0 million people in Europe suffer from non-healing wounds every year. It also reported that a burn patient in Germany was treated using prototype plasma treatment. Moreover, as per a research published by The National Center for Biotechnology Information (NCBI), a patient suffering with two second-degree burns was treated with cold plasma, which healed the itching and pain and presented new tissue after the second treatment. Such cases are anticipated to promote the usage of cold plasma in various wound treatments.

Cold Plasma Market Report Highlights:

The atomic pressure product segment led the market and accounted for the largest revenue share of 65.5% in 2023. This growth is attributed to the heavy utilization of atmospheric pressure cold plasma technology in various applications such as electronics, manufacturing, health care, etc.
The wound healing application segment dominated the market and accounted for the largest revenue share of 31.0% in 2023.
The North America cold plasma market dominated the global market and accounted for the largest revenue share of 41.3% in 2023.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Cold Plasma Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Cold Plasma Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Consumer Behavior Analysis

4.1. Demographic Analysis
4.2. Consumer Trends & Preferences
4.3. Factors Influencing Buying Decisions
4.4. Consumer Product Adoption Trends
4.5. Observations & Recommendations

Chapter 5. Cold Plasma Market: Pressure Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Cold Plasma Market: Pressure Movement Analysis, 2023 & 2030 (USD Million)
5.3. Low-Pressure Cold Plasma
- 5.3.1. Low-Pressure Cold Plasma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Atmospheric Pressure Cold Plasma
- 5.4.1. Atmospheric Pressure Cold Plasma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cold Plasma Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Cold Plasma Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Wound Healing
- 6.3.1. Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Blood Coagulation
- 6.4.1. Blood Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Dentistry
- 6.5.1. Dentistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Cancer Treatment
- 6.6.1. Cancer Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Other Medical Applications
- 6.7.1. Other Medical Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cold Plasma Market: Regional Estimates & Trend Analysis

7.1. Cold Plasma Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
  - 7.4.2.1. China Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
  - 7.4.3.1. Japan Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
  - 7.4.6.1. Australia Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Saudi Arabia
  - 7.6.2.1. Saudi Arabia Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. UAE
  - 7.6.3.1. UAE Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Africa
  - 7.6.4.1. South Africa Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Cold Plasma Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Bovie Medical Corporation.
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Neoplas med GmbH
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Europlasma NV
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. P2i Ltd.
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. U.S. Medical Innovations;
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Apyx Medical.
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Adtec Healthcare Limited.
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. terraplasma medical GmbH
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. CINOGY System GmbH
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives

저온 플라즈마 시장 규모, 점유율, 동향 분석 보고서 : 압력별, 용도별, 지역별, 부문별 예측(2024-2030년)

Cold Plasma Market Size, Share & Trends Analysis Report By Pressure, By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By Region, And Segment Forecasts, 2024 - 2030

저온 플라즈마 시장 성장과 동향:

저온 플라즈마 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 저온 플라즈마 시장 변수, 동향, 범위

제4장 소비자 행동 분석

제5장 저온 플라즈마 시장 : 압력 추정·동향 분석

제6장 저온 플라즈마 시장 : 용도 추정·동향 분석

제7장 저온 플라즈마 시장 : 지역 추정·동향 분석